Leo Wang

Dr. Leo Wang


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2017 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Open access
MCMinna H. Chen
Minna H. Chen
LWLeo Wang
Leo Wang
JCJennifer J. Chung
Jennifer J. Chung
YKYoung-Hun Kim
Young-Hun Kim
PAPavan Atluri
Pavan Atluri
Jason BurdickJason Burdick
Jason Burdick
Injectable hydrogels have gained popularity as a vehicle for the delivery of cells, growth factors, and other molecules to localize and improve their retention at the injection site, as well as for the mechanical bulking of tissues. However, there are many factors, such as viscosity, storage and loss moduli, and injection force, to consider when evaluating hydrogels for such applications. There are now numerous tools that can be used to quantitatively assess these factors, including for shear-thinning hydrogels because their properties change under mechanical load. Here, we describe relevant rheological tests and ways to measure injection force using a force sensor or a mechanical testing machine toward the evaluation of injectable hydrogels. Injectable, shear-thinning hydrogels can be used in a variety of clinical applications, and as an example we focus on methods for injection into the heart, where an understanding of injection properties and mechanical forces is imperative for consistent hydrogel delivery and retention. We discuss methods for delivery of hydrogels to mouse, rat, and pig hearts in models of myocardial infarction, and compare methods of tissue postprocessing for hydrogel preservation. Our intent is that the methods described herein can be helpful in the design and assessment of shear-thinning hydrogels for widespread biomedical applications.

12 December 2014 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
CRChristopher B. Rodell
Christopher B. Rodell
JMJohn W. MacArthur
John W. MacArthur
SDShauna M. Dorsey
Shauna M. Dorsey
RWRyan J. Wade
Ryan J. Wade
LWLeo Wang
Leo Wang
Jason BurdickJason Burdick
Jason Burdick

3 January 2018 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
LWLeo Wang
Leo Wang
CHChristopher B. Highley
Christopher B. Highley
YYYi‐Cheun Yeh
Yi‐Cheun Yeh
JGJonathan H. Galarraga
Jonathan H. Galarraga
SUSelen Uman
Selen Uman
Jason BurdickJason Burdick
Jason Burdick

27 November 2017 in Nature Biomedical Engineering
Verified
Journal Article
Open access
PDF file
LWLeo Wang
Leo Wang
YLYing Liu
Ying Liu
JCJennifer J. Chung
Jennifer J. Chung
TWTao Wang
Tao Wang
AGAnn C. Gaffey
Ann C. Gaffey
Jason BurdickJason Burdick
Jason Burdick
MicroRNA-based therapies that target cardiomyocyte proliferation have great potential for the treatment of myocardial infarction. In previous work, we showed that the miR-302/367 cluster regulates cardiomyocyte proliferation in the prenatal and postnatal heart. Here, we describe the development and application of an injectable hyaluronic acid hydrogel for the local and sustained delivery of miR-302 mimics to the heart. We show that the miR-302 mimics released in vitro promoted cardiomyocyte proliferation over one week, and that a single injection of the hydrogel in the mouse heart led to local and sustained cardiomyocyte proliferation for two weeks. After myocardial infarction, gel–miR-302 injection caused local clonal proliferation and increased cardiomyocyte numbers in the border zone of a Confetti mouse model. Gel–miR-302 further decreased cardiac end-diastolic (39%) and end-systolic (50%) volumes, and improved ejection fraction (32%) and fractional shortening (64%) four weeks after myocardial infarction and injection, compared with controls. Our findings suggest that biomaterial-based miRNA delivery systems can lead to improved outcomes via cardiac regeneration after myocardial infarction.

16 March 2018 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
CCCarol W Chen
Carol W Chen
LWLeo Wang
Leo Wang
SZSamir Zaman
Samir Zaman
JGJon Gordon
Jon Gordon
MAMaria F Arisi
Maria F Arisi
PAPavan Atluri
Pavan Atluri
Previous studies have demonstrated improved cardiac function following myocardial infarction (MI) after administration of endothelial progenitor cells (EPCs) into ischaemic myocardium. A growing body of literature supports paracrine effectors, including extracellular vesicles (EVs), as the main mediators of the therapeutic benefits of EPCs. The direct use of paracrine factors is an attractive strategy that harnesses the effects of cell therapy without concerns of cell engraftment or viability. We aim to reproduce the beneficial effects of EPC treatment through delivery of EPC-derived EVs within a shear-thinning gel (STG) for precise localization and sustained delivery. EVs were harvested from EPCs isolated from adult male Rattus norvegicus (Wistar) rats and characterized by electron microscopy, nanoparticle tracking analysis (NTA), and mass spectrometry. EVs were incorporated into the STG and injected at the border zone in rat models of MI. Haemodynamic function, angiogenesis, and myocardial remodelling were analyzed in five groups: phosphate buffered saline (PBS) control, STG control, EVs in PBS, EVs in STG, and EPCs in STG. Electron microscopy and NTA of EVs showed uniform particles of 50–200 nm. EV content analysis revealed several key angiogenic mediators. EV uptake by endothelial cells was confirmed and followed by robust therapeutic angiogenesis. In vivo animal experiments demonstrated that delivery of EVs within the STG resulted in increased peri-infarct vascular proliferation, preservation of ventricular geometry, and improved haemodynamic function post-MI. EPC-derived EVs delivered into ischaemic myocardium via an injectable hydrogel enhanced peri-infarct angiogenesis and myocardial haemodynamics in a rat model of MI. The STG greatly increased therapeutic efficiency and efficacy of EV-mediated myocardial preservation.

1 September 2018 in Journal of Controlled Release
Verified
Journal Article
Closed access
LWLeo Wang
Leo Wang
JCJennifer J. Chung
Jennifer J. Chung
ELElizabeth C. Li
Elizabeth C. Li
SUSelen Uman
Selen Uman
PAPavan Atluri
Pavan Atluri
Jason BurdickJason Burdick
Jason Burdick